Abstract

The mission of the Masonic Cancer Center (MCC) Flow Cytometry Shared Resource is to provide state-ofthe- art flow cytometry and cell sorting services, scientific consultation, and technical support to advance scientific discovery in a reliable and cost-effective manner. The Flow Cytometry Shared Resource underwent a major reorganization during the past period of support. It was consolidated in 2011 with other flow cytometry resources within the Academic Health Center at the University of Minnesota into a University Flow Cytometry Resource (UFCR). The reorganization reduced duplication in effort and other inefficiencies and made user rates more uniform and less subject to fluctuation. The former Director of the MCC Flow Cytometry Shared Resource, Dr. Tucker LeBien, now administers this new Academic Health Center facility. Many disciplines use this technology, but specific expertise is required to offer MCC members the best consultation for their projects. To maintain cancer-specific expertise, Dr. Christopher Pennell has replaced Dr. LeBien as Director of the MCC Flow Cytometry Shared Resource, which remains as a

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA077598-17
Application #
8935208
Study Section
Subcommittee G - Education (NCI)
Program Officer
Ciolino, Henry P
Project Start
Project End
Budget Start
2015-02-01
Budget End
2016-01-31
Support Year
17
Fiscal Year
2015
Total Cost
$128,926
Indirect Cost
$67,006

  Institution

Name
University of Minnesota Twin Cities
Department
Internal Medicine/Medicine
Type
DUNS #
555917996
City
Minneapolis
State
MN
Country
United States
Zip Code
55455

  Publications

How, Joan; Vij, Kiran R; Ebadi, Maryam et al. (2018) Prognostic value of prior consolidation in acute myeloid leukemia patients undergoing hematopoietic cell transplantation in minimal residual disease-negative first complete remission. Am J Hematol 93:E381-E383
Ustun, C; Brunstein, C; DeFor, T et al. (2018) Importance of conditioning regimen intensity, MRD positivity, and KIR ligand mismatch in UCB transplantation. Bone Marrow Transplant 53:97-100
Williams, Shelly M; Sumstad, Darin; Kadidlo, Diane et al. (2018) Clinical-scale production of cGMP compliant CD3/CD19 cell-depleted NK cells in the evolution of NK cell immunotherapy at a single institution. Transfusion 58:1458-1467
Kaizer, Alexander M; Hobbs, Brian P; Koopmeiners, Joseph S (2018) A multi-source adaptive platform design for testing sequential combinatorial therapeutic strategies. Biometrics 74:1082-1094
Sperduto, Paul W; Deegan, Brian J; Li, Jing et al. (2018) Estimating survival for renal cell carcinoma patients with brain metastases: an update of the Renal Graded Prognostic Assessment tool. Neuro Oncol 20:1652-1660
Li, Danni; Huang, Fangying; Zhao, Yingchun et al. (2018) Plasma lipoproteome in Alzheimer's disease: a proof-of-concept study. Clin Proteomics 15:31
Hwa Yun, Byeong; Guo, Jingshu; Bellamri, Medjda et al. (2018) DNA adducts: Formation, biological effects, and new biospecimens for mass spectrometric measurements in humans. Mass Spectrom Rev :
Yun, Byeong Hwa; Bellamri, Medjda; Rosenquist, Thomas A et al. (2018) Method for Biomonitoring DNA Adducts in Exfoliated Urinary Cells by Mass Spectrometry. Anal Chem 90:9943-9950
Rashidi, Armin; Shanley, Ryan; Yohe, Sophia L et al. (2018) Association between recipient TNF rs361525 and acute GVHD: results from analysis of BMT CTN-0201 samples. Bone Marrow Transplant 53:1069-1071
Owen, David L; Mahmud, Shawn A; Vang, Kieng B et al. (2018) Identification of Cellular Sources of IL-2 Needed for Regulatory T Cell Development and Homeostasis. J Immunol 200:3926-3933

Showing the most recent 10 out of 1013 publications